Priority Date: 30.12.11 (US 201161582050P)

MAKING AND USING IN VITRO-SYNTHESIZED ssRNA FOR INTRODUCING INTO MAMMALIAN CELLS TO INDUCE A BIOLOGICAL OR BIOCHEMICAL EFFECT

  • Application ID: EP12815983
  • Status: PATENT GRANTED

Attorney

operating since 1876
Headquarter in Hamburg and 2 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB and 171 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 30.12.2011 - Priority Date (US 201161582050P)
  • 04.07.2013 - Publication A1 (WO2013102203)
  • 05.11.2014 - Publication A1 (EP2798064)
  • 31.08.2016 - Publication B1 (EP2798064)